BW Online | March 26, 2001 | Pharmaceutical Time

U.S. EDITION
Full Table of Contents
Cover Story
Up Front
Readers Report
Technology & You
Letter From Brussels
Books
Economic Viewpoint
Economic Trends
Business Outlook
News: Analysis & Commentary

In Business This Week
Washington Outlook
International Business
International Outlook
Developments to Watch
People
Management
Government
The Corporation
Economics

Legal Affairs
BusinessWeek Investor
The Barker Portfolio
Inside Wall Street
Figures of the Week
Editorials

INTERNATIONAL EDITIONS
International -- Editor's Memo
International -- Spotlight on Argentina
International -- Readers Report
International -- Asian Business
International -- European Business
International -- Latin America
International -- Finance
International -- Int'l Figures of the Week
International -- Editorials

PREMIUM CONTENT MBA Insider

BW MAGAZINE Get Four Free Issues Register Subscribe Customer Service

ONLINE FEATURES Book Reviews BW Video Columnists Interactive Gallery Newsletters Past Covers Philanthropy Podcasts Special Reports BLOGS Auto Beat Bangalore Tigers Blogspotting Brand New Day Byte of the Apple Economics Unbound Eye on Asia Fine On Media Green Biz Hot Property Investing Insights Management IQ NEXT: Innovation NussbaumOnDesign Tech Beat Working Parents TECHNOLOGY J.D. Power Ratings Product Reviews Tech Stats Wildstrom: Tech Maven AUTOS Home Page Auto Reviews Classic Cars Car Care & Safety Hybrids INNOVATION
& DESIGN Home Page Architecture Brand Equity Auto Design Game Room SMALLBIZ Smart Answers Success Stories Today's Tip INVESTING Investing: Europe Annual Reports BW 50 S&P Picks & Pans Stock Screeners Free S&P Stock Report SCOREBOARDS Hot Growth 100 Mutual Funds Info Tech 100 S&P 500 B-SCHOOLS Undergrad Programs MBA Blogs MBA Profiles MBA Rankings Who's Hiring Grads

BW EXTRAS BW Digital BW Mobile BW Online Alerts Dashboard Widgets Podcasts RSS

RSS Feeds

Reprints/ Permissions Conferences Research Services

MARCH 26, 2001

INSIDE WALL STREET

Pharmaceutical Time

Gene G. Marcial

STORY TOOLS

Printer-Friendly Version

E-Mail This Story

Table: Healthy Bets

INSIDE WALL STREET

Pharmaceutical Time

Penn Treaty Could Be a Quick Gulp

Hair Salons: Regis Is on a Roll

With the market still very much under siege, buying growth stocks "at a reasonable price," as some advocate, is not nearly enough to protect and enhance a portfolio. What some pros advise now: Buy into growth companies endowed with defensive characteristics. Investment adviser Stephen Leeb recalls that survivors of past bear markets were defensive companies whose earning power stayed strong. So Leeb, editor of Personal Finance newsletter, advises taking refuge in drugmakers. Leeb's top choices: Quest Diagnostics (DGX ), Elan (ELN ), and Pfizer (PFE ).

"Well-situated drug companies have the potential for long-range steady and rapid growth," says Leeb. And they are defensive in that, no matter how the economy turns, people will need health care.

Quest Diagnostics, which provides diagnostic testing for doctors, has fallen from 146 a share in December to 88 on Mar. 14. Elan, an Irish company based in Dublin that makes medicines for pain and neurological disorders, is down from 60 to 48. It has transformed itself from a drug delivery and research outfit into a fast-growing drugmaker. But investors still value Elan on its former self, observes Leeb. Pfizer hasn't suffered all that much: Though off its 52-week high of 49, the stock isn't far behind, currently at 39.

The growth rates of both Elan and Quest exceed their price-earnings ratios, a positive sign. Pfizer's growth rate of 21.5%, however, is below its p-e of 29. But, notes Leeb, the company's projected growth is much more predictable than most other drugmakers. It has become a nearly "unstoppable marketing juggernaut" now that it has Warner Lambert in the fold, says Leeb.

By Gene G. Marcial

Get BusinessWeek directly on your desktop with our RSS feeds. XML

Add BusinessWeek news to your Web site with our headline feed.

Click to buy an e-print or reprint of a BusinessWeek or BusinessWeek Online story or video.

To subscribe online to BusinessWeek magazine, please click here.

Learn more, go to the BusinessWeekOnline home page